PyApp seems to be taking the Python world by storm, providing long-awaited click-and-run Python distribution. For developers who need a little more versatility, there’s uv. Find these tools and more ...

Replimune (REPL) stock plummets as report suggests FDA’s top regulator of cancer drugs intervened in rejecting its lead asset. Read more here.

Replimune Group, Inc. (REPL) Securities Class Action: The lawsuit is focused on the propriety of Replimune’s statements concerning data submitted to the FDA in support of its Biologics License ...

Replimune stock falls as FDA denies skin cancer drug approval and investors sue over alleged misstatements tied to the IGNYTE trial.

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in refractory melanoma. Click to read.

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).

ATLANTA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The lawsuit ...

The annual competition to raise awareness and eliminate the invasive Burmese python was held July 10-20, 2025 in the Everglades.

A Naples woman has emerged victorious in the annual Python Challenge, capturing 60 invasive Burmese pythons to win this year's competition. Taylor Stanberry was named the ultimate grand prize ...

Google has introduced LangExtract, an open-source Python library designed to help developers extract structured information from unstructured text using large language models such as the Gemini ...

NEW YORK - August 5, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit ...